Details for: DCAF5
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 20.69rCSI 50.28%PRS 27.73
-
CSI 19.52rCSI 32.77%PRS 28.54
-
CSI 18.06rCSI 56.44%PRS 29.68
-
CSI 15.98rCSI 57.49%PRS 27.47
-
CSI 15.63rCSI 18.72%PRS 62.7
-
CSI 12.86rCSI 48.6%PRS 29.51
-
CSI 10rCSI 58.89%PRS 29.91
-
CSI 9.93rCSI 8.63%PRS 52.48
-
CSI 8.15rCSI 14.37%PRS 41.93
-
CSI 7.97rCSI 32.16%PRS 42.05
-
CSI 7.62rCSI 10.77%PRS 52.33
-
CSI 6.85rCSI 21.91%PRS 40.46
-
CSI 6.71rCSI 17.34%PRS 39.75
-
CSI 6.56rCSI 28.87%PRS 37.25
-
CSI 6.44rCSI 20.13%PRS 31.91
-
CSI 6.26rCSI 4.67%PRS 61.78
-
CSI 6.13rCSI 23.69%PRS 62
-
CSI 6.04rCSI 7.01%PRS 54.2
-
CSI 5.8rCSI 9.33%PRS 30.6
-
CSI 5.72rCSI 42.07%PRS 32.05
-
CSI 5.71rCSI 7.8%PRS 45.91
-
CSI 5.42rCSI 6.5%PRS 41.54
-
CSI 5.16rCSI 11.8%PRS 42.83
-
CSI 5.01rCSI 11.06%PRS 32.38
-
CSI 4.95rCSI 8.89%PRS 37.12
-
CSI 4.79rCSI 8.29%PRS 34.6
-
CSI 4.54rCSI 6.92%PRS 40.25
-
CSI 4.47rCSI 7.89%PRS 27.56
-
CSI 4.42rCSI 5.18%PRS 58.87
-
CSI 4.37rCSI 24.69%PRS 30.5
-
CSI 4.35rCSI 6.94%PRS 37.55
-
CSI 4.32rCSI 7.12%PRS 48.87
-
CSI 4.14rCSI 3.15%PRS 54.57
-
CSI 4rCSI 3.36%PRS 60.59
-
CSI 3.88rCSI 4.82%PRS 27.1
-
CSI 3.86rCSI 5.54%PRS 50.68
-
CSI 3.85rCSI 8.79%PRS 37.26
-
CSI 3.85rCSI 4.94%PRS 41.49
-
CSI 3.8rCSI 5.08%PRS 51.6
-
CSI 3.78rCSI 2.63%PRS 51.7
-
CSI 3.77rCSI 3.84%PRS 56.32
-
CSI 3.74rCSI 6.66%PRS 58.96
-
CSI 3.71rCSI 5.05%PRS 56.28
-
CSI 3.45rCSI 8.72%PRS 51.57
-
CSI 3.39rCSI 3.33%PRS 45.57
-
CSI 3.37rCSI 2.49%PRS 37.38
-
CSI 3.33rCSI 2.58%PRS 43.81
-
CSI 3.25rCSI 7.11%PRS 53.34
-
CSI 3.24rCSI 2.33%PRS 56.11
-
CSI 3.1rCSI 3.64%PRS 47.09
-
CSI 3.07rCSI 2.39%PRS 60.11
-
CSI 3.01rCSI 2.67%PRS 42.48
-
CSI 3rCSI 7.81%PRS 42.58
-
CSI 2.98rCSI 6.59%PRS 40.75
-
CSI 2.97rCSI 3.78%PRS 48.5
-
CSI 2.94rCSI 5.62%PRS 60.13
-
CSI 2.81rCSI 7.42%PRS 50.78
-
CSI 2.79rCSI 3.33%PRS 28.52
-
CSI 2.75rCSI 65.91%PRS 28.05
-
CSI 2.75rCSI 3.82%PRS 42.88
-
CSI 2.74rCSI 2.17%PRS 31.76
-
CSI 2.72rCSI 2.04%PRS 46.65
-
CSI 2.65rCSI 4.65%PRS 36.12
-
CSI 2.63rCSI 2.31%PRS 53.04
-
CSI 2.63rCSI 3.38%PRS 39.26
-
CSI 2.61rCSI 5.24%PRS 33.82
-
CSI 2.59rCSI 62.52%PRS 28.93
-
CSI 2.59rCSI 2.45%PRS 44.37
-
CSI 2.58rCSI 1.74%PRS 53.42
-
CSI 2.55rCSI 7.56%PRS 55.11
-
CSI 2.55rCSI 2.66%PRS 42.99
-
CSI 2.54rCSI 5.6%PRS 47.36
-
CSI 2.53rCSI 22.27%PRS 32.68
-
CSI 2.52rCSI 6.55%PRS 48.65
-
CSI 2.51rCSI 14.48%PRS 45.66
-
CSI 2.51rCSI 2.61%PRS 44.07
-
CSI 2.51rCSI 2.33%PRS 43.27
-
CSI 2.5rCSI 3.67%PRS 39.72
-
CSI 2.47rCSI 2.28%PRS 63.56
-
CSI 2.47rCSI 9.25%PRS 36.88
-
CSI 2.42rCSI 38.18%PRS 47.87
-
CSI 2.42rCSI 6.94%PRS 60.65
-
CSI 2.41rCSI 3.01%PRS 54.77
-
CSI 2.39rCSI 1.66%PRS 56.09
-
CSI 2.36rCSI 2.08%PRS 33.09
-
CSI 2.36rCSI 1.85%PRS 49.73
-
CSI 2.35rCSI 5.42%PRS 35.73
-
CSI 2.34rCSI 3.19%PRS 48.1
-
CSI 2.33rCSI 1.38%PRS 58.18
-
CSI 2.33rCSI 4.83%PRS 41.42
-
CSI 2.3rCSI 11.04%PRS 41.98
-
CSI 2.29rCSI 2.51%PRS 47.18
-
CSI 2.27rCSI 6.57%PRS 45.9
-
CSI 2.25rCSI 10.77%PRS 45.21
-
CSI 2.23rCSI 5.73%PRS 46.42
-
CSI 2.23rCSI 6.58%PRS 47.36
-
CSI 2.22rCSI 2.04%PRS 50.58
-
CSI 2.21rCSI 3.42%PRS 53.41
-
CSI 2.16rCSI 3.2%PRS 48.24
-
CSI 2.16rCSI 3.49%PRS 42.01
-
CSI 0.2rCSI 1.9%PRS 64.0%
-
CSI 0.3rCSI 2.0%PRS 36.3%
-
CSI 0.3rCSI 1.3%PRS 55.2%
-
CSI 0.4rCSI 1.7%PRS 42.1%
-
CSI 0.4rCSI 4.0%PRS 83.2%
-
CSI 0.4rCSI 1.3%PRS 35.4%
-
CSI 0.5rCSI 1.0%PRS 45.3%
-
CSI 0.6rCSI 2.8%PRS 54.2%
-
CSI 0.6rCSI 0.7%PRS 39.4%
-
CSI 0.6rCSI 0.8%PRS 48.0%
-
CSI 0.7rCSI 4.3%PRS 49.9%
-
CSI 0.7rCSI 4.1%PRS 57.7%
-
CSI 0.7rCSI 1.0%PRS 45.3%
-
CSI 0.7rCSI 2.0%PRS 43.9%
-
CSI 0.7rCSI 1.4%PRS 53.5%
-
CSI 0.7rCSI 1.5%PRS 38.4%
-
CSI 0.8rCSI 8.2%PRS 45.0%
-
CSI 0.8rCSI 2.7%PRS 35.6%
-
CSI 0.8rCSI 2.1%PRS 51.7%
-
CSI 0.8rCSI 4.0%PRS 55.0%
-
CSI 0.8rCSI 2.6%PRS 42.8%
-
CSI 0.8rCSI 1.9%PRS 42.1%
-
CSI 0.8rCSI 1.3%PRS 60.7%
-
CSI 0.9rCSI 1.3%PRS 46.3%
-
CSI 0.9rCSI 2.1%PRS 33.5%
-
CSI 0.9rCSI 0.9%PRS 46.0%
-
CSI 0.9rCSI 3.6%PRS 46.4%
-
CSI 0.9rCSI 4.2%PRS 30.8%
-
CSI 1.0rCSI 2.7%PRS 57.8%
-
CSI 1.0rCSI 1.4%PRS 54.3%
-
CSI 1.0rCSI 1.2%PRS 56.7%
-
CSI 1.0rCSI 2.7%PRS 36.7%
-
CSI 1.0rCSI 3.9%PRS 37.3%
-
CSI 1.1rCSI 15.0%PRS 36.4%
-
CSI 1.1rCSI 1.0%PRS 40.2%
-
CSI 1.1rCSI 1.7%PRS 48.0%
-
CSI 1.1rCSI 2.6%PRS 61.5%
-
CSI 1.1rCSI 2.3%PRS 50.1%
-
CSI 1.1rCSI 1.8%PRS 34.6%
-
CSI 1.2rCSI 1.0%PRS 48.3%
-
CSI 1.2rCSI 10.3%PRS 31.6%
-
CSI 1.2rCSI 1.8%PRS 43.1%
-
CSI 1.2rCSI 3.1%PRS 34.5%
-
CSI 1.2rCSI 4.0%PRS 45.7%
-
CSI 1.3rCSI 1.9%PRS 50.2%
-
CSI 1.3rCSI 1.8%PRS 35.2%
-
CSI 1.3rCSI 2.0%PRS 47.1%
-
CSI 1.3rCSI 1.9%PRS 59.5%
-
CSI 1.3rCSI 2.8%PRS 34.2%
-
CSI 1.3rCSI 4.4%PRS 32.5%
-
CSI 1.4rCSI 1.5%PRS 41.4%
-
CSI 1.4rCSI 3.6%PRS 43.4%
-
CSI 1.4rCSI 3.3%PRS 53.5%
-
CSI 1.4rCSI 1.9%PRS 40.1%
-
CSI 1.4rCSI 5.4%PRS 52.2%
-
CSI 1.4rCSI 3.7%PRS 74.6%
-
CSI 1.5rCSI 2.8%PRS 33.7%
-
CSI 1.5rCSI 1.5%PRS 49.1%
-
CSI 1.5rCSI 2.5%PRS 64.2%
-
CSI 1.5rCSI 3.9%PRS 56.8%
-
CSI 1.5rCSI 2.3%PRS 44.0%
-
CSI 1.5rCSI 4.7%PRS 55.6%
-
CSI 1.5rCSI 3.8%PRS 39.7%
-
CSI 1.6rCSI 1.5%PRS 34.5%
-
CSI 1.6rCSI 5.1%PRS 32.9%
-
CSI 1.6rCSI 4.3%PRS 40.4%
-
CSI 1.6rCSI 2.6%PRS 34.6%
-
CSI 1.6rCSI 3.6%PRS 49.8%
-
CSI 1.6rCSI 2.0%PRS 51.0%
-
CSI 1.6rCSI 2.0%PRS 46.0%
-
CSI 1.6rCSI 3.9%PRS 45.7%
-
CSI 1.6rCSI 3.3%PRS 61.2%
-
CSI 1.6rCSI 2.3%PRS 40.5%
-
CSI 1.7rCSI 1.6%PRS 43.9%
-
CSI 1.7rCSI 2.9%PRS 51.9%
-
CSI 1.7rCSI 2.0%PRS 50.9%
-
CSI 1.7rCSI 4.1%PRS 41.5%
-
CSI 1.7rCSI 3.3%PRS 69.2%
-
CSI 1.7rCSI 34.4%PRS 37.7%
-
CSI 1.7rCSI 2.2%PRS 29.4%
-
CSI 1.7rCSI 2.7%PRS 36.9%
-
CSI 1.7rCSI 7.2%PRS 41.0%
-
CSI 1.7rCSI 6.6%PRS 63.7%
-
CSI 1.7rCSI 1.8%PRS 40.8%
-
CSI 1.7rCSI 3.9%PRS 29.2%
-
CSI 1.8rCSI 2.5%PRS 46.0%
-
CSI 1.8rCSI 2.3%PRS 48.1%
-
CSI 1.8rCSI 5.1%PRS 60.5%
-
CSI 1.8rCSI 3.2%PRS 41.8%
-
CSI 1.8rCSI 2.9%PRS 44.3%
-
CSI 1.8rCSI 4.0%PRS 57.9%
-
CSI 1.8rCSI 1.5%PRS 44.2%
-
CSI 1.8rCSI 5.2%PRS 43.5%
-
CSI 1.8rCSI 2.1%PRS 34.0%
-
CSI 1.9rCSI 4.4%PRS 49.2%
-
CSI 1.9rCSI 2.2%PRS 63.6%
-
CSI 1.9rCSI 2.2%PRS 38.0%
-
CSI 1.9rCSI 3.0%PRS 53.8%
-
CSI 1.9rCSI 1.8%PRS 44.3%
-
CSI 1.9rCSI 3.9%PRS 26.8%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 2059340477
Symbol: DCAF5_HUMAN
Name: DDB1- and CUL4-associated factor 5
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11347906
Title: Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
PubMed ID: 11347906
PubMed ID: 17974005
Title: The full-ORF clone resource of the German cDNA consortium.
PubMed ID: 17974005
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 9740667
Title: Genomic and functional map of the chromosome 14 t(12;14) breakpoint cluster region in uterine leiomyoma.
PubMed ID: 9740667
PubMed ID: 16949367
Title: A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1.
PubMed ID: 16949367
PubMed ID: 16964240
Title: Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery.
PubMed ID: 16964240
DOI: 10.1038/nature05175
PubMed ID: 19690332
Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
PubMed ID: 19690332
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 29691401
Title: Methylated DNMT1 and E2F1 are targeted for proteolysis by L3MBTL3 and CRL4-DCAF5 ubiquitin ligase.
PubMed ID: 29691401
PubMed ID: 30442713
Title: Proteolysis of methylated SOX2 protein is regulated by L3MBTL3 and CRL4-DCAF5 ubiquitin ligase.
PubMed ID: 30442713
Sequence Information:
- Length: 942
- Mass: 103963
- Checksum: 3C627BA3FB2DC522
- Sequence:
MKRRAGLGGS MRSVVGFLSQ RGLHGDPLLT QDFQRRRLRG CRNLYKKDLL GHFGCVNAIE FSNNGGQWLV SGGDDRRVLL WHMEQAIHSR VKPIQLKGEH HSNIFCLAFN SGNTKVFSGG NDEQVILHDV ESSETLDVFA HEDAVYGLSV SPVNDNIFAS SSDDGRVLIW DIRESPHGEP FCLANYPSAF HSVMFNPVEP RLLATANSKE GVGLWDIRKP QSSLLRYGGN LSLQSAMSVR FNSNGTQLLA LRRRLPPVLY DIHSRLPVFQ FDNQGYFNSC TMKSCCFAGD RDQYILSGSD DFNLYMWRIP ADPEAGGIGR VVNGAFMVLK GHRSIVNQVR FNPHTYMICS SGVEKIIKIW SPYKQPGCTG DLDGRIEDDS RCLYTHEEYI SLVLNSGSGL SHDYANQSVQ EDPRMMAFFD SLVRREIEGW SSDSDSDLSE STILQLHAGV SERSGYTDSE SSASLPRSPP PTVDESADNA FHLGPLRVTT TNTVASTPPT PTCEDAASRQ QRLSALRRYQ DKRLLALSNE SDSEENVCEV ELDTDLFPRP RSPSPEDESS SSSSSSSSED EEELNERRAS TWQRNAMRRR QKTTREDKPS APIKPTNTYI GEDNYDYPQI KVDDLSSSPT SSPERSTSTL EIQPSRASPT SDIESVERKI YKAYKWLRYS YISYSNNKDG ETSLVTGEAD EGRAGTSHKD NPAPSSSKEA CLNIAMAQRN QDLPPEGCSK DTFKEETPRT PSNGPGHEHS SHAWAEVPEG TSQDTGNSGS VEHPFETKKL NGKALSSRAE EPPSPPVPKA SGSTLNSGSG NCPRTQSDDS EERSLETICA NHNNGRLHPR PPHPHNNGQN LGELEVVAYS SPGHSDTDRD NSSLTGTLLH KDCCGSEMAC ETPNAGTRED PTDTPATDSS RAVHGHSGLK RQRIELEDTD SENSSSEKKL KT
Genular Protein ID: 1899331210
Symbol: Q8TBB7_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11237011
Title: Initial sequencing and analysis of the human genome.
PubMed ID: 11237011
DOI: 10.1038/35057062
PubMed ID: 11181995
PubMed ID: 12508121
Title: The DNA sequence and analysis of human chromosome 14.
PubMed ID: 12508121
DOI: 10.1038/nature01348
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 15496913
Title: Finishing the euchromatic sequence of the human genome.
PubMed ID: 15496913
DOI: 10.1038/nature03001
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
Sequence Information:
- Length: 326
- Mass: 36590
- Checksum: B56EF8095C053217
- Sequence:
MKRRAGLGGS MRSVVGFLSQ RGLHGDPLLT QDFQRRRLRG CRNLYKKDLL GHFGCVNAIE FSNNGGQWLV SGGDDRRVLL WHMEQAIHSR VKPIQLKGEH HSNIFCLAFN SGNTKVFSGG NDEQVILHDV ESSETLDVFA HEDAVYGLSV SPVNDNIFAS SSDDGRVLIW DIRESPHGEP FCLANYPSAF HSVMFNPVEP RLLATANSKE GVGLWDIRKP QSSLLRYGGN LSLQSAMSVR FNSNGTQLLA LRRRLPPVLY DIHSRLPVFQ FDNQGYFNSC TMKSCCFAGD RDQHHNWKWR AQAVSFQPFL SLTRNGDADV DLKLAV